GlassScriptPhysician profile
Peter Nakaji
NPI 1174518765
$160,367.10
in general payments reported to CMS, 2019-2025
19 companies · $3,628 in 2025
The $3,628 reported for 2025 was more than what 77% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153K · 2020: $12.96 · 2021: $255 · 2022: $2,335 · 2023: $378 · 2024: $1,085 · 2025: $3,628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,400 · Food and Beverage: $2,146 · Travel and Lodging: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,400.00 |
| Food and Beverage | $2,146.38 |
| Travel and Lodging | $544.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $150,188.02 | 2019-2022 | |
| Acumed LLC | $3,134.31 | 2022-2025 | Osteomed |
| Gt Medical Technologies, INC | $3,094.90 | 2019-2025 | Gammatile |
| Aesculap, INC. | $2,218.45 | 2019 | |
| Brainlab, INC. | $346.79 | 2022 | |
| Zap Surgical Systems, INC. | $334.55 | 2019-2022 | |
| Longeviti Neuro Solutions INC | $190.94 | 2025 | Clearfit |
| Monteris Medical Corporation | $179.90 | 2019-2023 | Neuroblate |
| Isoray, INC | $166.69 | 2019 | |
| Nico Corporation | $131.94 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $123.32 | 2024 | |
| Ossdsign USA Incorporated | $82.36 | 2023 | |
| Stryker Corporation | $45.68 | 2021 | |
| Eisai INC. | $36.23 | 2019 | |
| Globus Medical, INC. | $27.15 | 2023 | Excelsiusgps Robotic Navigation System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $23.24 | 2025 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Livanova USA, INC. | $18.88 | 2019 | |
| Orthofix Medical, INC. | $12.96 | 2020 | |
| Novartis Pharmaceuticals Corporation | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Nakaji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.